| Dec 24, 2025 | TargED Biopharmaceuticals | $25.4M Series A Extension | Rianne Ellenbroek | Andera Partners, INKEF Capital, Curie Capital, Hadean Ventures, Sunstone Life Science Ventures |
| Oct 1, 2025 | Tubulis | $360.0M Series C | Venrock | 5AM Ventures, Abingworth, Andera Partners, Coparion, EQT Life Sciences, Frazier Healthcare Partners, Hakan Goker, Third Rock Ventures, Versant Ventures, Lorence Kim, Bayern Kapital, Deep Track Capital, Patrick Heron, Frank Hensel, LSP, Nextech Invest, OCCIDENT, Seventure Partners, Wellington Management |
| Mar 14, 2024 | Tubulis GmbH | $140.1M Series B | Christoph Broja, Kanishka Pothula | Sofia Ioannidou, Bayern Kapital, BioMedPartners, coparion, Deep Track Capital, Evotec, Frazier Life Sciences, Caroline Goddeeris, High-Tech Grunderfonds, OCCIDENT, Seventure Partners |
| Nov 3, 2022 | Novadip Biosciences | $23.6M Series B | — | Olivier van der Rest, Pierre Drion, CR-CP Life Science Fund, InvestSud, SRIW, VIVES Louvain Technology Fund |
| Aug 27, 2022 | Etherna | $38.9M Series B | Marijn Dekkers | Kenneth Chien, Grand Pharma, LSP, Omega Funds, PMV |
| Aug 25, 2022 | AstriVax | $29.9M Seed | Caroline Goddeeris, Shelley Margetson | Ackermans & van Haaren, BNP Paribas Fortis Private Equity, Flanders Future Tech Fund, KU Leuven, Merieux Equity Partners, Thuja Capital |
| May 1, 2022 | Minoryx Therapeutics | $55.0M Series C | Caixa Capital, Damià Tormo | CDTI, Ysios Capital |
| May 1, 2022 | Tubulis | $63.0M Series B | Andera Partners | 5AM Ventures, Abingworth, Coparion, EQT Life Sciences, Frazier Healthcare Partners, Hakan Goker, Third Rock Ventures, Venrock, Versant Ventures, Bayern Kapital, Valentin Piech, Thomas Hanke, Jan Van den Bossche, High-Tech Grunderfonds, OCCIDENT, Seventure Partners |
| Feb 1, 2022 | TargED Biopharmaceuticals | $44.0M Series A | Andera Partners, INKEF Capital, Jan Van den Bossche, Roger Franklin, Jacob Lange Moresco | Ysios Capital, Mariette van der Velden, FIRST, Utrecht Health Seed Fund |
| Oct 28, 2021 | Novadip Biosciences | $22.1M Series B | Jason Zhou | Invest.BW, InvestSud, Franssen Christina, VIVES Louvain Technology Fund |
| Aug 1, 2021 | Cardior Pharmaceuticals | $75.0M Series B | INKEF Capital | BioMedPartners, Bristol Myers Squibb, coparion, Hadean Ventures, High-Tech Grunderfonds, Karin Kleinhans, Sunstone Capital |
| May 24, 2021 | ExeVir Bio | $50.0M Series A | Philippe Monteyne | Belgian family offices, Noshaq, Sambrinvest, Stef HEYLEN, MD, Caroline THIELEN, Erica Whittaker, Katja Rosenkranz, Jerome Van Biervliet, Joël Henneghien |
| Jul 28, 2020 | ExeVir Bio | $27.0M Other Equity | Philippe Monteyne | SFPI-FPIM, Erica Whittaker, Katja Rosenkranz, Jerome Van Biervliet |
| Jul 27, 2020 | Indigo Diabetes | $44.4M Series B | Jan Van den Bossche | Ackermans & van Haaren, Capricorn Venture Partners, imec.xpand, QBICII, Titan Baratto |
| Jun 16, 2020 | etherna immunotherapies | $38.4M Series B | — | BNP Paribas Fortis Private Equity, Boehringer Ingelheim, Grand Decade, LSP, Novalis LifeSciences, Omega Funds, PMV, Yijing Capital |
| Jun 16, 2020 | Etherna | $38.4M Series B | — | BNP Paribas Fortis Private Equity, Boehringer Ingelheim Venture Fund, Grand Decade, LSP, Novalis LifeSciences, Omega Funds, PMV, Yijing Capital |
| Jun 1, 2020 | Ona Therapeutics | $34.0M Series A | — | Alta Life Sciences, Andera Partners, EQT Life Sciences, Forbion, Kurma Partners, Sanofi Ventures, Ysios Capital, Clara Campas, Jean-François Morin, Alexandra Tolia |
| Mar 1, 2020 | ITeos Therapeutics | $130.0M Series B | Aaron Davis, Derek DiRocco | RA Capital, 6 Dimensions Capital, Curative Ventures, HBM Partners, Invus, Janus Henderson Investors, MPM Capital, RTW Investments, SFPI, SRIW, VIVES Louvain Technology Fund |
| Sep 26, 2018 | Minoryx Therapeutics | $25.1M Series B | Philippe Monteyne | Caixa Capital Risc, Chiesi Ventures, HealthEquity, Idinvest Partners, Kurma Partners, Roche, Sambrinvest, SFPI, Gery Lefebvre, Ysios Capital |
| Jun 1, 2018 | ITeos Therapeutics | $75.0M Series B | MPM Capital | Atlas Venture, Hakan Goker, RA Capital, 6 Dimensions Capital, Curative Ventures, Priyanka Belawat, SFPI, SRIW, VIVES Louvain Technology Fund |
| Dec 11, 2017 | Aelin Therapeutics | $31.8M Series A | — | Boehringer Ingelheim, John de Koning, Novartis, PMV |
| Sep 5, 2017 | Immunic Therapeutics | $11.9M Series A Extension | Jörg Neermann | Jan Van den Bossche, Vincent Ossipow |
| Oct 28, 2016 | Promethera Biosciences | $10.9M Series C Extension | — | Boehringer Ingelheim, Cell Innovation Partners, LifeLiver, Muneki Handa, SMS Investments, SRIW, Vesalius Biocapital |
| Oct 2, 2015 | Euroscreen | $18.0M Series B | Fund+, SFPI-FPIM | BNP Paribas Fortis Private Equity, Capricorn Venture Partners, SRIW, Vesalius Biocapital |
| Sep 10, 2015 | Novadip Biosciences | $31.5M Series A | — | Epim 'e'de, Integral Venture Partners, SFPI-FPIM, SRIW, Startup Capital Ventures, VIVES Louvain Technology Fund |
